Javid Safa

405 total citations
26 papers, 336 citations indexed

About

Javid Safa is a scholar working on Surgery, Nephrology and Molecular Biology. According to data from OpenAlex, Javid Safa has authored 26 papers receiving a total of 336 indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Surgery, 6 papers in Nephrology and 5 papers in Molecular Biology. Recurrent topics in Javid Safa's work include Lipoproteins and Cardiovascular Health (4 papers), Biochemical Acid Research Studies (4 papers) and Metabolism and Genetic Disorders (3 papers). Javid Safa is often cited by papers focused on Lipoproteins and Cardiovascular Health (4 papers), Biochemical Acid Research Studies (4 papers) and Metabolism and Genetic Disorders (3 papers). Javid Safa collaborates with scholars based in Iran, United States and Spain. Javid Safa's co-authors include Reza Mahdavi, Nariman Nezami, Hassan Argani, Amir Ghorbanihaghjo, Mehran Mesgari Abbasi, Mohammadreza Ardalan, Nadereh Rashtchizadeh, Khalil Ansarin, Hamid Noshad and Bahar Bastani and has published in prestigious journals such as SHILAP Revista de lepidopterología, Clinical Biochemistry and ˜The œNephron journals/Nephron journals.

In The Last Decade

Javid Safa

26 papers receiving 314 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Javid Safa Iran 11 87 70 53 51 50 26 336
Cebrail Gürsul Türkiye 10 27 0.3× 59 0.8× 33 0.6× 24 0.5× 45 0.9× 30 351
Vicente Giner Spain 8 65 0.7× 130 1.9× 34 0.6× 15 0.3× 13 0.3× 15 579
Fatemeh Eshraghi-Jazi Iran 17 28 0.3× 58 0.8× 113 2.1× 8 0.2× 69 1.4× 34 707
Murat Dikmengil Türkiye 10 40 0.5× 95 1.4× 51 1.0× 9 0.2× 24 0.5× 22 449
Murat Bolayırlı Türkiye 14 20 0.2× 143 2.0× 24 0.5× 23 0.5× 32 0.6× 48 545
Lori A. Smolin United States 13 173 2.0× 65 0.9× 18 0.3× 16 0.3× 20 0.4× 21 778
Salwa A. Ibrahim Egypt 9 45 0.5× 74 1.1× 20 0.4× 7 0.1× 69 1.4× 14 351
Ender Dulundu Türkiye 12 51 0.6× 91 1.3× 13 0.2× 20 0.4× 86 1.7× 30 606
J R McMurray United Kingdom 9 14 0.2× 41 0.6× 68 1.3× 23 0.5× 26 0.5× 16 347
G Clifton United States 13 55 0.6× 245 3.5× 24 0.5× 19 0.4× 155 3.1× 24 530

Countries citing papers authored by Javid Safa

Since Specialization
Citations

This map shows the geographic impact of Javid Safa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Javid Safa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Javid Safa more than expected).

Fields of papers citing papers by Javid Safa

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Javid Safa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Javid Safa. The network helps show where Javid Safa may publish in the future.

Co-authorship network of co-authors of Javid Safa

This figure shows the co-authorship network connecting the top 25 collaborators of Javid Safa. A scholar is included among the top collaborators of Javid Safa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Javid Safa. Javid Safa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Mahdavi, Reza, et al.. (2019). Alpha lipoic acid supplementation improved antioxidant enzyme activities in hemodialysis patients. International Journal for Vitamin and Nutrition Research. 89(3-4). 161–167. 15 indexed citations
2.
Nezami, Nariman, Kamyar Ghabili, Morteza Ghojazadeh, et al.. (2018). The Relationship between Carotid and Femoral Artery Intima-Media Thickness and Histopathologic Grade of Atherosclerosis in Patients with Chronic Kidney Disease. ˜The œNephron journals/Nephron journals. 139(2). 159–169. 5 indexed citations
3.
Ghorbanihaghjo, Amir, et al.. (2017). Serum sTWEAK and FGF-23 Levels in Hemodialysis and Renal Transplant Patients.. SHILAP Revista de lepidopterología. 8(2). 110–116. 11 indexed citations
4.
Naghavi‐Behzad, Mohammad, et al.. (2016). Short-term effects of lovastatin therapy on proteinuria of type 2 diabetic nephropathy: A clinical trial study. Nigerian Medical Journal. 57(5). 253–253. 1 indexed citations
5.
Beiraghdar, Fatemeh, Yunes Panahi, Behzad Einollahi, et al.. (2015). Evaluation of a biosimilar recombinant alpha epoetin in the management of anemia in hemodialysis patients. Saudi Pharmaceutical Journal. 23(5). 544–548. 2 indexed citations
6.
Ghorbanihaghjo, Amir, et al.. (2014). Fetuin-A and vitamin D receptor gene polymorphisms in hemodialysis patients. SHILAP Revista de lepidopterología. 1 indexed citations
7.
Noshad, Hamid, et al.. (2014). Effect of hemodialysis on pulmonary function tests and plasma endothelin levels. Saudi Journal of Kidney Diseases and Transplantation. 25(4). 781–781. 5 indexed citations
8.
Safa, Javid, et al.. (2014). Effects of alpha lipoic acid supplementation on serum levels of IL-8 and TNF-α in patient with ESRD undergoing hemodialysis. International Urology and Nephrology. 46(8). 1633–1638. 24 indexed citations
9.
Ghorbanihaghjo, Amir, Javid Safa, Samira Alizadeh, et al.. (2013). Protective Effect of Fish Oil Supplementation on DNA Damage Induced by Cigarette Smoking. Journal of Health Population and Nutrition. 31(3). 343–9. 18 indexed citations
10.
Nezami, Nariman, et al.. (2012). Effect of Lovastatin on Serum Osteoprotegerin Level in Type 2 Diabetic Nephropathy. SHILAP Revista de lepidopterología. 1 indexed citations
11.
Nezami, Nariman, et al.. (2012). Effect of Lovastatin Therapy and Withdrawal on Serum Uric Acid Level in People With Type 2 Diabetic Nephropathy. Nucleosides Nucleotides & Nucleic Acids. 31(4). 353–363. 8 indexed citations
12.
Argani, Hassan, et al.. (2012). Serum Fetuin-A and Pentraxin3 in hemodialysis and renal transplant patients. Clinical Biochemistry. 45(10-11). 775–779. 14 indexed citations
13.
Rashtchizadeh, Nadereh, et al.. (2012). Serum Receptor Activator of Nuclear Factor‐κ B Ligand, Osteoprotegrin, and Intact Parathyroid Hormone in Hemodialysis and Renal Transplant Patients. Therapeutic Apheresis and Dialysis. 16(6). 600–604. 6 indexed citations
14.
15.
Nezami, Nariman, Amir Ghorbanihaghjo, Hassan Argani, et al.. (2010). Lovastatin enhances paraoxonase enzyme activity and quells low-density lipoprotein susceptibility to oxidation in type 2 diabetic nephropathy. Clinical Biochemistry. 44(2-3). 165–170. 8 indexed citations
16.
Nezami, Nariman, et al.. (2010). Lovastatin raises serum osteoprotegerin level in people with type 2 diabetic nephropathy. Clinical Biochemistry. 43(16-17). 1294–1299. 12 indexed citations
17.
Safa, Javid, et al.. (2009). Post-transplant urological and vascular complications.. PubMed. 20(5). 867–71. 8 indexed citations
18.
19.
Ghorbanihaghjo, Amir, et al.. (2008). Effect of Isoproterenol on Cyclosporine-Induced Nephrotoxicity in Rat. Transplantation Proceedings. 40(10). 3737–3741. 4 indexed citations
20.
Noshad, Hamid, Mohammadreza Ardalan, Mojgan Mortazavi, et al.. (2007). Kidney Transplantation Candidates and Cardiovascular Risk Factors. Transplantation Proceedings. 39(4). 871–874. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Cebrail Gürsul Breakdown of academic impact, for papers by Vicente Giner Breakdown of academic impact, for papers by Fatemeh Eshraghi-Jazi Breakdown of academic impact, for papers by Murat Dikmengil Breakdown of academic impact, for papers by Murat Bolayırlı Breakdown of academic impact, for papers by Lori A. Smolin Breakdown of academic impact, for papers by Salwa A. Ibrahim Breakdown of academic impact, for papers by Ender Dulundu Breakdown of academic impact, for papers by J R McMurray Breakdown of academic impact, for papers by G Clifton
Rankless by CCL
2026